Celularity (CELU) Non Operating Investment Income (2019 - 2020)
Celularity (CELU) posted quarterly Non Operating Investment Income of $60088.0 for Q3 2020, up 202.43% year-over-year from $19868.1 in Q4 2019, and up 112.74% quarter-over-quarter from -$471500.0 in Q2 2020.
Celularity (CELU) Non Operating Investment Income (2019 - 2020) Analysis & Trends
Celularity (CELU) has reported Non Operating Investment Income for 2 consecutive years, with $60088.0 the latest figure, recorded in Q3 2020.
- In Q3 2020, Non Operating Investment Income rose 202.43% year-over-year to $60088.0; the TTM figure through Sep 2020 stood at -$177325.0 (changed N/A YoY), while the FY2019 annual figure was -$7871.0, changed N/A from the prior year.
- Non Operating Investment Income improved to $60088.0 in Q3 2020 per CELU's latest filing, from -$471500.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $429890.0 in Q1 2020 and bottomed at -$471500.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 60,088.00 |
| Sep 30, 2020 | 60,088.00 |
| Jun 30, 2020 | -471,500.00 |
| Jun 30, 2020 | -471,500.00 |
| Mar 31, 2020 | 429,890.00 |
| Mar 31, 2020 | 429,890.00 |
| Dec 31, 2019 | -195,803.00 |
| Dec 31, 2019 | -195,803.00 |
| Sep 30, 2019 | -58,660.00 |
| Sep 30, 2019 | -58,660.00 |
| Jun 30, 2019 | 246,592.00 |
| Jun 30, 2019 | 246,592.00 |